Arvieux C C, Videcoq M, Ramsay J G, Stone J G, Foëx P, Ryder W A
Département d'Anesthésie et de Réanimation Chirurgicale, Grenoble, France.
Br J Anaesth. 1991 Jun;66(6):673-82. doi: 10.1093/bja/66.6.673.
Global and regional myocardial functions were studied in seven open-chest dogs with constant low plasma concentrations of verapamil as increasing concentrations of isoflurane (0.75, 1, 1.5 MAC) were administered in the presence of normal myocardial perfusion and after application of critical constriction of the left anterior descending coronary artery. In the presence of verapamil, increases in isoflurane concentrations caused dose-dependent myocardial depression both before and after critical coronary constriction. The systemic and coronary vasodilatation associated with high concentrations of isoflurane did not occur in the presence of verapamil. The association of verapamil with isoflurane caused regional myocardial dysfunction that worsened at high isoflurane concentrations. This regional dysfunction could not be antagonized in two dogs. The effects of isoflurane on regional function were not modified by application of a critical coronary constriction.
在七只开胸犬中研究了整体和局部心肌功能,在正常心肌灌注情况下以及应用左前降支冠状动脉临界缩窄后,给予恒定低血浆浓度维拉帕米的同时增加异氟烷浓度(0.75、1、1.5MAC)。在维拉帕米存在的情况下,无论冠状动脉临界缩窄前后,异氟烷浓度增加均引起剂量依赖性心肌抑制。在维拉帕米存在时,与高浓度异氟烷相关的全身和冠状动脉血管扩张未出现。维拉帕米与异氟烷联合导致局部心肌功能障碍,在高异氟烷浓度时加重。在两只犬中这种局部功能障碍无法被拮抗。冠状动脉临界缩窄并未改变异氟烷对局部功能的影响。